Skip to main content
Equibles
XNCR logo

XNCR · Xencor Inc

Track XNCR — free

Use XNCR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.51 -1.40 (-5.02%) At close · Sep 2
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.99B
Shares
74.35M

XNCR metrics

67 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$27.91
Market cap
$1.99B

Price action

19 metrics
Price change (1W)
-4.7%
Price change (30D)
+43.9%
Price change (3M)
+149.0%
Price change (6M)
+132.2%
Price change (YTD)
+82.3%
Price change (1Y)
+243.3%
Trailing year
Price change (5Y)
-19.8%
52-week high
$29.30
52-week low
$8.31
Change from 52-week high
-4.7%
Change from 52-week low
+235.9%
Annualized volatility
66.9%
Beta
1.2
RSI (14D)
65.6
Price vs SMA 50
+37.3%
Price vs SMA 200
+86.5%
Avg volume (3M)
1.13M
Relative volume
1.3
Average dollar volume
$22.21M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
74.35M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
18.6×
reciprocal yield 5.4%
P / book
3.9
reciprocal yield 25.8%
FCF yield
-10.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.3%

Historical valuation

8 metrics
P / E historical average (3Y)
55.3×
reciprocal yield 1.8%
P / E historical average (5Y)
55.3×
reciprocal yield 1.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-05

Profitability

9 metrics
Gross margin
—
Operating margin
-205.8%
Trailing 12 months
Net margin
-155.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$216.08M
Net income (TTM)
−$163.11M
Trailing 12 months
Diluted EPS (TTM)
$-2.17
FCF margin
-198.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.35

Growth

11 metrics
Revenue growth YoY
+17.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$104.97M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.1%
Year over year · more shares
Revenue CAGR (3Y)
-8.6%
Revenue CAGR (5Y)
+0.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-32.4%
Return on assets
-22.5%
Debt / equity
0.2
Current ratio
6.4
EBITDA (TTM)
−$205.79M
Free cash flow (TTM)
−$208.28M
Quick ratio
6.4
Interest coverage
-8.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$44.66M
Total assets
$724.96M
Total debt
$104.89M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$205.81M
Capital expenditures (TTM)
$2.47M
R&D (TTM)
$255.76M
SG&A (TTM)
—
Stock compensation (TTM)
$39.03M
R&D / revenue
243.6%
Stock compensation / revenue
37.2%

Ownership (13F)

3 metrics
13F filers
208
13F filer change QoQ
+5
Institutional ownership
113.2%

Short interest

3 metrics
Short interest
19.1%
Latest settlement · 14.1 days to cover
Days to cover
14.1d
Short-squeeze score
86 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$379,135
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1326732 CUSIP 98401F105 13F (30d) 164 filings 164 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)